|
US20050239054A1
(en)
*
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
|
TWI332956B
(en)
*
|
2002-04-26 |
2010-11-11 |
Gilead Sciences Inc |
Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
|
|
EP1565428A1
(en)
*
|
2002-11-27 |
2005-08-24 |
Elan Pharmaceuticals, Inc. |
Substituted ureas and carbamates
|
|
US20040224917A1
(en)
|
2003-01-14 |
2004-11-11 |
Gilead Sciences, Inc. |
Compositions and methods for combination antiviral therapy
|
|
EP1620110A2
(en)
*
|
2003-04-25 |
2006-02-01 |
Gilead Sciences, Inc. |
Immunomodulator phosphonate conjugates
|
|
US7470724B2
(en)
*
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7407965B2
(en)
*
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
US20050261237A1
(en)
*
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
|
US7300924B2
(en)
*
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
|
WO2004096237A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
US7427636B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
WO2004096233A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates
|
|
US20090247488A1
(en)
*
|
2003-04-25 |
2009-10-01 |
Carina Cannizzaro |
Anti-inflammatory phosphonate compounds
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
MXPA05011296A
(es)
*
|
2003-04-25 |
2006-01-24 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de la cinasa.
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
ATE490788T1
(de)
|
2003-04-25 |
2010-12-15 |
Gilead Sciences Inc |
Antivirale phosphonate analoge
|
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
|
WO2005044279A1
(en)
*
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
WO2005044308A1
(en)
*
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
JP2007508843A
(ja)
*
|
2003-10-24 |
2007-04-12 |
ギリアード サイエンシーズ， インコーポレイテッド |
治療用化合物の同定のための方法および組成物
|
|
US20080287471A1
(en)
*
|
2003-12-22 |
2008-11-20 |
Maria Fardis |
4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
|
|
US20050153990A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Watkins William J. |
Phosphonate substituted kinase inhibitors
|
|
BRPI0418031A
(pt)
*
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
|
AU2004308974A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
MXPA06007906A
(es)
*
|
2004-01-12 |
2007-02-14 |
Gilead Sciences Inc |
Compuestos antivirales de fosfonato de pirimidilo y metodos de uso.
|
|
ES2315922T3
(es)
*
|
2004-04-14 |
2009-04-01 |
Gilead Sciences, Inc. |
Analogos de fosfonato de compuestos inhibidores de la integrasa del vih.
|
|
ES2720618T3
(es)
*
|
2004-07-27 |
2019-07-23 |
Gilead Sciences Inc |
Análogos de fosfonato de compuestos de inhibidores de VIH
|
|
AU2011218664B2
(en)
*
|
2004-07-27 |
2014-08-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
RS50981B
(sr)
*
|
2004-09-17 |
2010-10-31 |
Idenix Pharmaceuticals Inc. |
Fosfoindoli kao hiv inhibitori
|
|
ES2354338T3
(es)
*
|
2004-09-17 |
2011-03-14 |
Idenix Pharmaceuticals, Inc. |
Fosfoindoles como inhibidores de vih.
|
|
CN101072561B
(zh)
|
2004-10-07 |
2011-05-11 |
生命医药公司 |
二氨基烷烃天冬氨酸蛋白酶抑制剂
|
|
BRPI0518013A
(pt)
|
2004-11-15 |
2008-10-21 |
Ceptyr Inc |
inibidores de proteìna tirosina fosfatase, composição farmacêutica, complexo e métodos de uso dos mesmos
|
|
EP1831235B1
(en)
|
2004-12-16 |
2013-02-20 |
The Regents of The University of California |
Lung-targeted drugs
|
|
JP5260965B2
(ja)
|
2005-02-25 |
2013-08-14 |
テイボテク・フアーマシユーチカルズ |
プロテアーゼ阻害剤前駆体合成
|
|
JP2008535862A
(ja)
*
|
2005-04-08 |
2008-09-04 |
キメリクス，インコーポレイテッド |
ポックスウイルス感染の治療のための化合物、組成物および方法
|
|
US20070003608A1
(en)
*
|
2005-04-08 |
2007-01-04 |
Almond Merrick R |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
|
AR053845A1
(es)
|
2005-04-15 |
2007-05-23 |
Tibotec Pharm Ltd |
5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
TWI471145B
(zh)
*
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
BRPI0613962A2
(pt)
|
2005-07-25 |
2009-03-24 |
Intermune Inc |
inibidores macrocìclicos inovadores de replicação de vìrus da hepatite c
|
|
CA2616314A1
(en)
*
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
|
GEP20104956B
(en)
*
|
2005-10-11 |
2010-04-12 |
Array Biopharma Inc |
Compounds for inhibiting hepatitis c viral replication and use thereof
|
|
TWI411607B
(zh)
|
2005-11-14 |
2013-10-11 |
Vitae Pharmaceuticals Inc |
天門冬胺酸蛋白酶抑制劑
|
|
AR057182A1
(es)
|
2005-11-28 |
2007-11-21 |
Tibotec Pharm Ltd |
Compuestos de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
|
|
AR058238A1
(es)
|
2005-11-28 |
2008-01-23 |
Tibotec Pharm Ltd |
Compuestos y derivados de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
|
|
AU2006325404B2
(en)
*
|
2005-12-14 |
2012-03-01 |
Cipla Limited |
Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit
|
|
US20070167422A1
(en)
*
|
2006-01-18 |
2007-07-19 |
Yu Kwok S |
Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
|
|
KR101395377B1
(ko)
*
|
2006-03-29 |
2014-05-14 |
길리애드 사이언시즈, 인코포레이티드 |
Ｈｉｖ 단백질 분해 효소 억제제 및 그를 포함하는 약학 조성물
|
|
US20090312318A1
(en)
*
|
2006-07-24 |
2009-12-17 |
Desai Manoj C |
Therapeutic compounds and methods
|
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
|
US7960428B2
(en)
|
2006-09-29 |
2011-06-14 |
Idenix Pharmaceuticals, Inc. |
Enantiomerically pure phosphoindoles as HIV inhibitors
|
|
EP2121589A2
(en)
*
|
2006-12-18 |
2009-11-25 |
University of Massachusetts |
Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease
|
|
US7981929B2
(en)
*
|
2007-03-16 |
2011-07-19 |
Sequoia Pharmaceuticals, Inc. |
Benzofuran derived HIV protease inhibitors
|
|
CA2681718A1
(en)
*
|
2007-03-23 |
2008-10-02 |
University Of Massachusetts |
Hiv-1 protease inhibitors
|
|
NZ581606A
(en)
*
|
2007-05-03 |
2012-06-29 |
Intermune Inc |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
|
WO2008151306A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Synthesis of cyclodepsipeptide compounds having antineoplastic and/or antimicrobial activity
|
|
KR20100041798A
(ko)
|
2007-06-29 |
2010-04-22 |
한국화학연구원 |
신규 ｈｉｖ 역전사효소 억제제
|
|
CA2692460A1
(en)
|
2007-06-29 |
2009-01-08 |
Korea Research Institute Of Chemical Technology |
Hiv reverse transcriptase inhibitors
|
|
US7964843B2
(en)
|
2008-07-18 |
2011-06-21 |
The George Washington University |
Three-dimensional molecular imaging by infrared laser ablation electrospray ionization mass spectrometry
|
|
US8067730B2
(en)
|
2007-07-20 |
2011-11-29 |
The George Washington University |
Laser ablation electrospray ionization (LAESI) for atmospheric pressure, In vivo, and imaging mass spectrometry
|
|
US20100285446A1
(en)
*
|
2007-07-20 |
2010-11-11 |
Akos Vertes |
Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
|
|
US8901487B2
(en)
*
|
2007-07-20 |
2014-12-02 |
George Washington University |
Subcellular analysis by laser ablation electrospray ionization mass spectrometry
|
|
US8119800B2
(en)
|
2007-12-21 |
2012-02-21 |
Korea Research Institute Of Chemical Technology |
Processes for preparing HIV reverse transcriptase inhibitors
|
|
WO2009094190A2
(en)
*
|
2008-01-25 |
2009-07-30 |
Chimerix, Inc. |
Methods of treating viral infections
|
|
AP2010005416A0
(en)
*
|
2008-04-15 |
2010-10-31 |
Intermune Inc |
Novel macrocyclic inhibitors of hepatitis c virus replication.
|
|
LT2300013T
(lt)
*
|
2008-05-21 |
2017-12-27 |
Ariad Pharmaceuticals, Inc. |
Fosforo dariniai kaip kinazių inhibitoriai
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
WO2009158377A1
(en)
*
|
2008-06-26 |
2009-12-30 |
Smith Kline Beecham Corporation |
Salts of methyl 2-((r))-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
|
|
UA103329C2
(ru)
|
2008-07-08 |
2013-10-10 |
Гилиад Сайенсиз, Инк. |
Соли соединений-ингибиторов вич
|
|
CN102216321A
(zh)
*
|
2008-10-15 |
2011-10-12 |
因特蒙公司 |
治疗性抗病毒肽
|
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
|
EA201100851A1
(ru)
|
2008-12-23 |
2012-04-30 |
Фармассет, Инк. |
Аналоги нуклеозидов
|
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
AR075584A1
(es)
*
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
EP2270021A1
(en)
|
2009-06-18 |
2011-01-05 |
Centre National de la Recherche Scientifique |
Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
|
|
WO2010151476A2
(en)
|
2009-06-25 |
2010-12-29 |
Gilead Sciences, Inc. |
Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate
|
|
US7924650B2
(en)
*
|
2009-06-30 |
2011-04-12 |
Oracle America, Inc. |
Dynamically controlled voltage regulator for a memory
|
|
CA2804190A1
(en)
|
2009-07-02 |
2011-01-06 |
Newgen Therapeutics, Inc. |
Phosphorus containing quinazoline compounds and methods of use
|
|
WO2011011519A1
(en)
|
2009-07-21 |
2011-01-27 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
|
DE102009041443A1
(de)
*
|
2009-09-16 |
2011-03-31 |
Archimica Gmbh |
Salze des 6-Chlor-4-(cyclopropylethinyl)-1,4-dihydro-4-(trifluormethyl)-2H-3,1-benzoxazin-2-ons und deren Synthese, Aufreinigung und Anwendung als Vorstufen für Efavirenz
|
|
US20110129444A1
(en)
*
|
2009-09-28 |
2011-06-02 |
Intermune, Inc |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
|
TW201116540A
(en)
*
|
2009-10-01 |
2011-05-16 |
Intermune Inc |
Therapeutic antiviral peptides
|
|
AU2010313273B2
(en)
*
|
2009-10-30 |
2015-04-02 |
Emergent Biodefense Operations Lansing Llc |
Methods of treating viral associated diseases
|
|
DK2534150T3
(en)
|
2010-02-12 |
2017-06-12 |
Chimerix Inc |
METHODS OF TREATING VIRUS INFECTION
|
|
EP2609923B1
(en)
|
2010-03-31 |
2017-05-24 |
Gilead Pharmasset LLC |
Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
|
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
|
BR112012024884A2
(pt)
|
2010-03-31 |
2016-10-18 |
Gilead Pharmasset Llc |
síntese estereosseletiva de ativos contendo fósforo
|
|
US9278135B2
(en)
|
2010-04-26 |
2016-03-08 |
Chimerix Inc. |
Methods of treating retroviral infections and related dosage regimes
|
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
|
AR084044A1
(es)
|
2010-11-30 |
2013-04-17 |
Pharmasset Inc |
Compuestos 2’-espiro-nucleosidos
|
|
CN102127030B
(zh)
*
|
2011-01-21 |
2013-05-22 |
天津大学 |
4-(取代-1,3-二炔基)-4-(三氟甲基)苯并-1,4-二氢噁嗪-2-酮类化合物及其制备方法和应用
|
|
CN103501612B
(zh)
|
2011-05-04 |
2017-03-29 |
阿里亚德医药股份有限公司 |
抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
|
|
ES2629913T3
(es)
|
2011-05-19 |
2017-08-16 |
Gilead Sciences, Inc. |
Procesos e intermediarios para la preparación de agentes anti-VIH
|
|
CA2841752A1
(en)
|
2011-07-14 |
2013-06-13 |
The George Washington University |
Plume collimation for laser ablation electrospray ionization mass spectrometry
|
|
ES2467145T3
(es)
*
|
2011-07-18 |
2014-06-12 |
Essilor International (Compagnie Générale d'Optique) |
Máquina para revestir un artículo óptico con una composición de revestimiento antisuciedad y procedimiento para utilizar la máquina
|
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
|
WO2013086217A1
(en)
|
2011-12-06 |
2013-06-13 |
Masco Corporation Of Indiana |
Ozone distribution in a faucet
|
|
WO2013169401A1
(en)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
|
RS57796B1
(sr)
|
2013-03-15 |
2018-12-31 |
Univ California |
Diestri acikličnog nukleozid fosfonata
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
EP3116511B1
(en)
|
2014-03-14 |
2020-08-26 |
Alltech, Inc. |
Compositions of selenoorganic compounds and methods of use thereof
|
|
WO2016039403A1
(ja)
*
|
2014-09-11 |
2016-03-17 |
塩野義製薬株式会社 |
持続性ｈｉｖプロテアーゼ阻害剤
|
|
SG11201701957XA
(en)
|
2014-09-15 |
2017-04-27 |
Univ California |
Nucleotide analogs
|
|
EP3212196A4
(en)
|
2014-10-29 |
2018-07-11 |
Wisconsin Alumni Research Foundation |
Boronic acid inhibitors of hiv protease
|
|
ES2892123T3
(es)
|
2014-12-26 |
2022-02-02 |
Univ Emory |
Derivados antivíricos de N4-hidroxicitidina
|
|
WO2016187788A1
(en)
|
2015-05-25 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds useful for treating hiv infection
|
|
EP3350191B9
(en)
|
2015-09-15 |
2021-12-22 |
The Regents of the University of California |
Nucleotide analogs
|
|
WO2017048252A1
(en)
|
2015-09-15 |
2017-03-23 |
Alltech, Inc. |
Compositions of selenoorganic compounds and methods of use thereof
|
|
WO2017072361A1
(en)
|
2015-10-30 |
2017-05-04 |
Nbe-Therapeutics Ag |
Anti-ror1 antibodies
|
|
WO2017087257A1
(en)
|
2015-11-17 |
2017-05-26 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors
|
|
CN115093008B
(zh)
|
2015-12-21 |
2024-05-14 |
德尔塔阀门公司 |
包括消毒装置的流体输送系统
|
|
EP3405496B1
(en)
|
2016-01-20 |
2023-10-25 |
University of Florida Research Foundation, Incorporated |
Ror1 antibody compositions and related methods
|
|
CN107709288A
(zh)
*
|
2016-02-03 |
2018-02-16 |
四川海思科制药有限公司 |
一种磷酰胺衍生物及制备方法和用途
|
|
CN106045874B
(zh)
*
|
2016-05-20 |
2017-12-05 |
大连医科大学 |
二苯甲酮‐二酮酸类化合物，组合物及用途
|
|
JOP20190130A1
(ar)
|
2016-12-02 |
2019-06-02 |
Merck Sharp & Dohme |
مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
|
|
JP2020500866A
(ja)
|
2016-12-02 |
2020-01-16 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｈｉｖインテグラーゼ阻害剤として有用な三環式複素環化合物
|
|
EP3601331A4
(en)
*
|
2017-03-16 |
2021-01-20 |
Evolve Biologics Inc. |
ALBUMIN PURIFICATION PROCESS
|
|
CN109305990B
(zh)
*
|
2017-07-28 |
2021-02-26 |
四川海思科制药有限公司 |
一种磷酸衍生物及制备方法和用途
|
|
CN109305989B
(zh)
*
|
2017-07-28 |
2021-02-26 |
四川海思科制药有限公司 |
一种磷酰胺衍生物及制备方法和用途
|
|
PL3661937T3
(pl)
|
2017-08-01 |
2021-12-20 |
Gilead Sciences, Inc. |
Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych
|
|
SG11202000846WA
(en)
|
2017-08-07 |
2020-02-27 |
Nbe Therapeutics Ag |
Anthracycline-based antibody drug conjugates having high in vivo tolerability
|
|
GB2581936B
(en)
|
2017-12-07 |
2021-02-10 |
Univ Emory |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
|
US11542288B2
(en)
*
|
2020-06-01 |
2023-01-03 |
University Of Massachusetts |
Antiviral compounds
|
